RxDoctor Payments Data

Bassam Hasan, MD

Infectious Disease · Brick, NJNPI 1346246097

Payments from drug & device makers

$585in general payments, 2019–2025

Across 7 payments — averaging $83.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$125
  • Organogenesis Inc.$120
  • AbbVie$115
  • Shionogi Inc$112
  • UCB, Inc.$95
  • Celltrion USA Inc.$19

What the payments were for

  • Food & beverage$585100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis1$125
Organogenesis Inc.2$120
AbbVie1$115
Shionogi Inc1$112
UCB, Inc.1$95
Celltrion USA Inc.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$585 in reported general payments places this provider in the 50th percentile of 334 infectious disease providers in New Jersey.

See all infectious disease providers in New Jersey

Medicare billing

Part B allowed, 2024
$237,287
Medicare patients
447
Services billed
1,829

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in Brick

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →